672324-80-0 Usage
Uses
Used in Pharmaceutical Industry:
5-Pyrimidinemethanamine, 2-amino(9CI) is used as a starting material for the synthesis of various pharmaceuticals. Its unique chemical structure allows it to be easily modified and incorporated into a wide range of drug molecules, making it a valuable component in the development of new medications.
Used in Agrochemical Industry:
In the agrochemical industry, 5-Pyrimidinemethanamine, 2-amino(9CI) is used as a starting material for the synthesis of various agrochemicals. Its ability to be modified and incorporated into different chemical structures makes it a useful component in the development of new pesticides and other agricultural chemicals.
Used in Antibacterial Applications:
5-Pyrimidinemethanamine, 2-amino(9CI) has been studied for its potential biological activities, including its role as an antibacterial agent. Its ability to inhibit bacterial growth makes it a promising candidate for use in the development of new antibiotics and other antimicrobial agents.
Used in Research and Development:
Due to its versatile properties and potential applications, 5-Pyrimidinemethanamine, 2-amino(9CI) is of interest to researchers in various fields of science and industry. It is used as a research compound to explore its potential uses and to develop new methods for its synthesis and modification. This research can lead to the discovery of new applications and the development of innovative products in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 672324-80-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,2,3,2 and 4 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 672324-80:
(8*6)+(7*7)+(6*2)+(5*3)+(4*2)+(3*4)+(2*8)+(1*0)=160
160 % 10 = 0
So 672324-80-0 is a valid CAS Registry Number.
InChI:InChI=1/C5H8N4/c6-1-4-2-8-5(7)9-3-4/h2-3H,1,6H2,(H2,7,8,9)
672324-80-0Relevant articles and documents
OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES
-
Page/Page column 176, (2016/03/19)
Disclosed are compounds active towards nuclear receptors, pharmaceutical compositions containing the compounds and use of the compounds in therapy.
NOVEL JNK INHIBITORS
-
Page/Page column 98, (2008/12/07)
Disclosed are substituted imidazo[1,2-a]pyridines, imidazo[1,2-a]pyrazines, imidazo[1,2-c]pyrimidines and imidazo[1,2-d]triazines compounds of the formula: (1.0) Also disclosed are methods for treating JNK1 and ERK mediated diseases using the compounds of formula 1.0.
Pyrazolotriazines as kinase inhibitors
-
Page/Page column 17, (2008/06/13)
In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]triazine compounds as inhibitors of kinases such as, for example, cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing
PYRAZOLOPYRIMIDINES AS CYCLIN-DEPENDENT KINASE INHIBITORS
-
Page 94-95, (2008/06/13)
In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.